NCI-60:修订间差异
删除的内容 添加的内容
第77行: | 第77行: | ||
! 细胞系 !! 性别 !! 倍增时间 !! 文献 !! 外部链接 |
! 细胞系 !! 性别 !! 倍增时间 !! 文献 !! 外部链接 |
||
|- |
|- |
||
| [[LOX-IMVI]] || 男 || 20.5h || <ref>{{cite journal |last1=Fodstad |first1=O |last2=Aamdal |first2=S |last3=McMenamin |first3=M |last4=Nesland |first4=JM |last5=Pihl |first5=A |title=A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. |journal=International journal of cancer |date=1988-03-15 |volume=41 |issue=3 |pages=442-9 |doi=10.1002/ijc.2910410322 |pmid=3346110}}</ref> || [https://www.cellosaurus.org/CVCL_1381 CVCL_1381] |
|||
| [[LOX-IMVI]] || || 20.5h || || |
|||
|- |
|- |
||
| [[Malme-3M]] || 男 || 46.2h || <ref>{{cite journal |last1=Fogh |first1=Jørgen |last2=Trempe |first2=Germain |title=New Human Tumor Cell Lines |journal=Human Tumor Cells in Vitro |date=1975 |pages=115–159 |doi=10.1007/978-1-4757-1647-4_5}}</ref> || [https://www.cellosaurus.org/CVCL_1438 CVCL_1438] |
|||
| [[Malme-3M]] || || 46.2h || || |
|||
|- |
|- |
||
| [[M14细胞|M14]] || || 26.3h || || |
| [[M14细胞|M14]] || || 26.3h || || |
2024年1月30日 (二) 11:45的版本
NCI-60是美国国家癌症研究所(National Cancer Institute,NCI)列出的60种人类癌症细胞系的列表[1],用于抗癌药物筛选等科学研究[2]。
细胞系
白血病
细胞系 | 类型 | 性别 | 倍增时间 | 文献 | 外部链接 |
---|---|---|---|---|---|
CCRF-CEM | 急性淋巴性白血病 | 女 | 26.7h | [3] | CVCL_0207 |
HL-60 | 急性早幼粒细胞白血病 | 女 | 28.6h | [4] | CVCL_0002 |
K-562 | 慢性髓细胞性白血病 | 女 | 19.6h | [5][6] | CVCL_0004 |
MOLT-4 | 急性淋巴性白血病 | 男 | 27.9h | [7] | CVCL_0013 |
RPMI-8226 | 多發性骨髓瘤 | 男 | 33.5h | [8] | CVCL_0014 |
SR-786 | 间变性大细胞淋巴瘤 | 男 | 28.7h | [9] | CVCL_1711 |
非小细胞肺癌
细胞系 | 性别 | 倍增时间 | 文献 | 外部链接 |
---|---|---|---|---|
A549 | 男 | 22.9h | [10] | CVCL_0023 |
EKVX | 男 | 43.6h | [11] | CVCL_1195 |
HOP-62 | 女 | 39h | [12] | CVCL_1285 |
HOP-92 | 男 | 79.5h | [13] | CVCL_1286 |
NCI-H226 | 男 | 61h | [14] | CVCL_1544 |
NCI-H23 | 男 | 33.4h | [14] | CVCL_1547 |
NCI-H322M | 男 | 35.3h | [14] | CVCL_1557 |
NCI-H460 | 男 | 17.8h | [14] | CVCL_0459 |
NCI-H522 | 男 | 38.2h | [14] | CVCL_1567 |
结直肠癌
细胞系 | 性别 | 倍增时间 | 文献 | 外部链接 |
---|---|---|---|---|
COLO 205 | 男 | 23.8h | [15] | CVCL_0218 |
HCC2998 | 未知 | 31.5h | [16] | CVCL_1266 |
HCT 166 | 男 | 17.4h | [17] | CVCL_0291 |
HCT 15 | 男 | 20.6h | [18] | CVCL_0292 |
HT-29 | 女 | 19.5h | [19] | CVCL_0320 |
KM12 | 男 | 23.7h | [20] | CVCL_1331 |
SW620 | 男 | 20.4h | [21] | CVCL_0547 |
中枢神经系统
细胞系 | 性别 | 倍增时间 | 文献 | 外部链接 |
---|---|---|---|---|
[[]] | h |
黑色素瘤
细胞系 | 性别 | 倍增时间 | 文献 | 外部链接 |
---|---|---|---|---|
LOX-IMVI | 男 | 20.5h | [22] | CVCL_1381 |
Malme-3M | 男 | 46.2h | [23] | CVCL_1438 |
M14 | 26.3h | |||
SK-MEL-2 | 45.5h | |||
SK-MEL-28 | 35.1h | |||
SK-MEL-5 | 25.2h | |||
UACC-257 | 38.5h | |||
UACC-62 | 31.3h |
卵巢癌
细胞系 | 倍增时间 | 文献 | 外部链接 |
---|---|---|---|
IGROV-1 | 31h | [24] | CVCL_1304 |
OVCAR-3 | 34.7h | [25] | CVCL_0465 |
OVCAR-4 | 41.4h | [25] | CVCL_1627 |
OVCAR-5 | 48.8h | [25] | CVCL_1628 |
OVCAR-8 | 26.1h | [25] | CVCL_1629 |
SK-OV-3 | 48.7h | [26] | CVCL_0532 |
肾癌
细胞系 | 性别 | 倍增时间 | 文献 | 外部链接 |
---|---|---|---|---|
786-O | 男 | 22.4h | [27] | CVCL_1051 |
A-498 | 男 | 66.8h | [28] | CVCL_1056 |
ACHN | 男 | 27.5h | [29] | CVCL_1067 |
CAKI-1 | 男 | 39h | [30] | CVCL_0234 |
RXF 393 | 男 | 62.9h | [31] | CVCL_1673 |
SN12C | 男 | 29.5h | [32] | CVCL_1705 |
TK-10 | 男 | 51.3h | [33] | CVCL_1773 |
UO-31 | 女 | 41.7h | [34] | CVCL_1911 |
前列腺癌
细胞系 | 性别 | 倍增时间 | 文献 | 外部链接 |
---|---|---|---|---|
PC-3 | 男 | 27.1h | [35] | CVCL_0035 |
DU145 | 男 | 32.3h | [36] | CVCL_0105 |
乳腺癌
细胞系 | 类型 | 倍增时间 | 文献 | 外部链接 |
---|---|---|---|---|
MCF-7 | HR+ | 25.4h | [37] | CVCL_0031 |
MDA-MB-231 | 三陰性乳癌 | 41.9h | [38] | CVCL_0062 |
MDA-MB-468 | 三陰性乳癌 | 62h | [39] | CVCL_0419 |
Hs 578T | 三陰性乳癌 | 53.8h | [40] | CVCL_0332 |
BT-549 | 三陰性乳癌 | 53.9h | [41] | CVCL_1092 |
T-47D | HR+ | 45.5h | [42] | CVCL_0553 |
參考資料
- ^ NCI-60 Human Tumor Cell Lines Screen | Discovery & Development Services | Developmental Therapeutics Program (DTP). dtp.cancer.gov.
- ^ Abaan, OD; Polley, EC; Davis, SR; Zhu, YJ; Bilke, S; Walker, RL; Pineda, M; Gindin, Y; Jiang, Y; Reinhold, WC; Holbeck, SL; Simon, RM; Doroshow, JH; Pommier, Y; Meltzer, PS. The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.. Cancer research. 2013-07-15, 73 (14): 4372–82. PMID 23856246. doi:10.1158/0008-5472.CAN-12-3342.
- ^ FOLEY, GE; LAZARUS, H; FARBER, S; UZMAN, BG; BOONE, BA; MCCARTHY, RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. April 1965, 18 (4): 522–9. PMID 14278051. S2CID 32647486. doi:10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j .
- ^ Gallagher, R; Collins, S; Trujillo, J; McCredie, K; Ahearn, M; Tsai, S; Metzgar, R; Aulakh, G; Ting, R; Ruscetti, F; Gallo, R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.. Blood. September 1979, 54 (3): 713–33. PMID 288488. doi:10.1182/blood.V54.3.713.713 .
- ^ Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. March 1975, 45 (3): 321–334. PMID 163658. doi:10.1182/blood.V45.3.321.321 .
- ^ Drexler HG. The Leukemia-Lymphoma Cell Line Factsbook. San Diego: Academic Press. 2000.
- ^ Minowada, J; Onuma, T; Moore, GE. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.. Journal of the National Cancer Institute. September 1972, 49 (3): 891–5. PMID 4567231.
- ^ Matsuoka, Y; Moore, GE; Yagi, Y; Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.. Proceedings of the Society for Experimental Biology and Medicine. August 1967, 125 (4): 1246–50. PMID 6042436. S2CID 9643262. doi:10.3181/00379727-125-32327.
- ^ Su, IJ; Balk, SP; Kadin, ME. Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies.. The American Journal of Pathology. August 1988, 132 (2): 192–8. PMC 1880737 . PMID 2456698.
- ^ Giard, DJ; Aaronson, SA; Todaro, GJ; Arnstein, P; Kersey, JH; Dosik, H; Parks, WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.. Journal of the National Cancer Institute. 1973-11, 51 (5): 1417–23. PMID 4357758. doi:10.1093/jnci/51.5.1417.
- ^ Aamdal, S; Fodstad, O; Kaalhus, O; Pihl, A. Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors.. International journal of cancer. 1986-04-15, 37 (4): 579–87. PMID 3957463. doi:10.1002/ijc.2910370417.
- ^ Hubbard, WC; Alley, MC; Gray, GN; Green, KC; McLemore, TL; Boyd, MR. Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors.. Cancer research. 1989-02-15, 49 (4): 826–32. PMID 2536293.
- ^ Monks, A; Scudiero, D; Skehan, P; Shoemaker, R; Paull, K; Vistica, D; Hose, C; Langley, J; Cronise, P; Vaigro-Wolff, A. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.. Journal of the National Cancer Institute. 1991-06-05, 83 (11): 757–66. PMID 2041050. doi:10.1093/jnci/83.11.757.
- ^ 14.0 14.1 14.2 14.3 14.4 Alley, MC; Scudiero, DA; Monks, A; Hursey, ML; Czerwinski, MJ; Fine, DL; Abbott, BJ; Mayo, JG; Shoemaker, RH; Boyd, MR. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.. Cancer research. 1988-02-01, 48 (3): 589–601. PMID 3335022.
- ^ Björk, P; Jönsson, U; Svedberg, H; Larsson, K; Lind, P; Dillner, J; Hedlund, G; Dohlsten, M; Kalland, T. Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody.. The Journal of biological chemistry. 1993-11-15, 268 (32): 24232–41 [2019-12-09]. PMID 7693697.
- ^ Alley, MC; Scudiero, DA; Monks, A; Hursey, ML; Czerwinski, MJ; Fine, DL; Abbott, BJ; Mayo, JG; Shoemaker, RH; Boyd, MR. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.. Cancer research. 1988-02-01, 48 (3): 589–601. PMID 3335022.
- ^ Rajput, A; Dominguez San Martin, I; Rose, R; Beko, A; Levea, C; Sharratt, E; Mazurchuk, R; Hoffman, RM; Brattain, MG; Wang, J. Characterization of HCT116 human colon cancer cells in an orthotopic model.. The Journal of surgical research. 2008-06-15, 147 (2): 276–81 [2019-12-31]. PMID 17961596. doi:10.1016/j.jss.2007.04.021. (原始内容存档于2019-12-31).
- ^ Zhao, J; Wen, G; Ding, M; Pan, JY; Yu, ML; Zhao, F; Weng, XL; Du, JL. Comparative proteomic analysis of colon cancer cell HCT-15 in response to all-trans retinoic acid treatment.. Protein and peptide letters. 2012-12, 19 (12): 1272–80 [2020-02-17]. PMID 22670670. doi:10.2174/092986612803521675. (原始内容存档于2020-02-18).
- ^ Martínez-Maqueda, D; et al. HT29 Cell Line. The Impact of Food Bioactives on Health. Springer. 2015: 113–124. ISBN 978-3-319-15791-7. PMID 29787047. doi:10.1007/978-3-319-16104-4_11.
- ^ Monks, A; Scudiero, D; Skehan, P; Shoemaker, R; Paull, K; Vistica, D; Hose, C; Langley, J; Cronise, P; Vaigro-Wolff, A. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.. Journal of the National Cancer Institute. 1991-06-05, 83 (11): 757–66. PMID 2041050. doi:10.1093/jnci/83.11.757.
- ^ Leibovitz, A; Stinson, JC; McCombs WB, 3rd; McCoy, CE; Mazur, KC; Mabry, ND. Classification of human colorectal adenocarcinoma cell lines.. Cancer research. 1976-12, 36 (12): 4562–9. PMID 1000501.
- ^ Fodstad, O; Aamdal, S; McMenamin, M; Nesland, JM; Pihl, A. A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX.. International journal of cancer. 1988-03-15, 41 (3): 442–9. PMID 3346110. doi:10.1002/ijc.2910410322.
- ^ Fogh, Jørgen; Trempe, Germain. New Human Tumor Cell Lines. Human Tumor Cells in Vitro. 1975: 115–159. doi:10.1007/978-1-4757-1647-4_5.
- ^ Bénard, J; Da Silva, J; De Blois, MC; Boyer, P; Duvillard, P; Chiric, E; Riou, G. Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice.. Cancer research. 1985-10, 45 (10): 4970–9 [2020-02-17]. PMID 3861241. (原始内容存档于2020-02-17).
- ^ 25.0 25.1 25.2 25.3 Hamilton, TC; Young, RC; Ozols, RF. Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches.. Seminars in oncology. 1984-09, 11 (3): 285–98. PMID 6385258.
- ^ Fogh, J; Fogh, JM; Orfeo, T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.. Journal of the National Cancer Institute. 1977-07, 59 (1): 221–6 [2020-01-17]. PMID 327080. doi:10.1093/jnci/59.1.221. (原始内容存档于2020-01-12).
- ^ Williams, RD; Elliott, AY; Stein, N; Fraley, EE. In vitro cultivation of human renal cell cancer. I. Establishment of cells in culture.. In vitro. 1976-09, 12 (9): 623–7. PMID 1010528. doi:10.1007/BF02797460.
- ^ Giard, DJ; Aaronson, SA; Todaro, GJ; Arnstein, P; Kersey, JH; Dosik, H; Parks, WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.. Journal of the National Cancer Institute. 1973-11, 51 (5): 1417–23. PMID 4357758. doi:10.1093/jnci/51.5.1417.
- ^ Kochevar, J. Blockage of autonomous growth of ACHN cells by anti-renal cell carcinoma monoclonal antibody 5F4.. Cancer research. 1990-05-15, 50 (10): 2968–72 [2019-12-02]. PMID 2334900.
- ^ Breuksch, I; Prosinger, F; Baehr, F; Engelhardt, FP; Bauer, HK; Thüroff, JW; Heimes, AS; Hasenburg, A; Prawitt, D; Brenner, W. Integrin α5 triggers the metastatic potential in renal cell carcinoma.. Oncotarget. 2017-12-08, 8 (64): 107530–107542 [2019-12-09]. PMID 29296184. doi:10.18632/oncotarget.22501.
- ^ Monks, A; Scudiero, D; Skehan, P; Shoemaker, R; Paull, K; Vistica, D; Hose, C; Langley, J; Cronise, P; Vaigro-Wolff, A. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.. Journal of the National Cancer Institute. 1991-06-05, 83 (11): 757–66. PMID 2041050. doi:10.1093/jnci/83.11.757.
- ^ Naito, S; von Eschenbach, AC; Giavazzi, R; Fidler, IJ. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice.. Cancer research. 1986-08, 46 (8): 4109–15. PMID 3731078.
- ^ Bear, A; Clayman, RV; Elbers, J; Limas, C; Wang, N; Stone, K; Gebhard, R; Prigge, W; Palmer, J. Characterization of two human cell lines (TK-10, TK-164) of renal cell cancer.. Cancer research. 1987-07-15, 47 (14): 3856–62. PMID 3594443.
- ^ Alley, MC; Scudiero, DA; Monks, A; Hursey, ML; Czerwinski, MJ; Fine, DL; Abbott, BJ; Mayo, JG; Shoemaker, RH; Boyd, MR. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.. Cancer research. 1988-02-01, 48 (3): 589–601. PMID 3335022.
- ^ Kaighn, ME; Narayan, KS; Ohnuki, Y; Lechner, JF; Jones, LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3).. Investigative urology. 1979-07, 17 (1): 16–23 [2020-01-13]. PMID 447482. (原始内容存档于2020-01-13).
- ^ Stone, KR; Mickey, DD; Wunderli, H; Mickey, GH; Paulson, DF. Isolation of a human prostate carcinoma cell line (DU 145).. International journal of cancer. 1978-03-15, 21 (3): 274–81. PMID 631930. doi:10.1002/ijc.2910210305.
- ^ Lee, Adrian V.; et al. MCF-7 Cells—Changing the Course of Breast Cancer Research and Care for 45 Years. Journal of the National Cancer Institute. 1 July 2015, 107 (7): djv073. PMID 25828948. doi:10.1093/jnci/djv073.
- ^ Cailleau, R; Young, R; Olivé, M; Reeves WJ, Jr. Breast tumor cell lines from pleural effusions.. Journal of the National Cancer Institute. 1974-09, 53 (3): 661–74. PMID 4412247. doi:10.1093/jnci/53.3.661.
- ^ Cailleau, R; Olivé, M; Cruciger, QV. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization.. In vitro. 1978-11, 14 (11): 911–5 [2020-02-14]. PMID 730202. doi:10.1007/bf02616120. (原始内容存档于2020-02-14).
- ^ Hackett, AJ; Smith, HS; Springer, EL; Owens, RB; Nelson-Rees, WA; Riggs, JL; Gardner, MB. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines.. Journal of the National Cancer Institute. 1977-06, 58 (6): 1795–806. PMID 864756. doi:10.1093/jnci/58.6.1795.
- ^ Lasfargues, EY; Coutinho, WG; Redfield, ES. Isolation of two human tumor epithelial cell lines from solid breast carcinomas.. Journal of the National Cancer Institute. 1978-10, 61 (4): 967–78 [2019-12-07]. PMID 212572. (原始内容存档于2013-12-17).
- ^ Yu, S; Kim, T; Yoo, KH; Kang, K. The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer.. Biochemical and biophysical research communications. 2017-05-06, 486 (3): 752–758 [2019-11-30]. PMID 28342866. doi:10.1016/j.bbrc.2017.03.114.